Cargando…
Polymer chimera of stapled oncolytic peptide coupled with anti-PD-L1 peptide boosts immunotherapy of colorectal cancer
Rationale: Scarce tumor mutation burden and neoantigens create tremendous obstacles for an effective immunotherapy of colorectal cancer (CRC). Oncolytic peptides rise as a promising therapeutic approach that boosts tumor-specific immune responses by inducing antigenic substances. However, the clinic...
Autores principales: | Lu, Lu, Zhang, He, Zhou, Yudong, Lin, Jiayi, Gao, Weidong, Yang, Ting, Jin, Jinmei, Zhang, Lijun, Nagle, Dale G., Zhang, Weidong, Wu, Ye, Chen, Hongzhuan, Luan, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065177/ https://www.ncbi.nlm.nih.gov/pubmed/35547769 http://dx.doi.org/10.7150/thno.71129 |
Ejemplares similares
-
The peptide PROTAC modality: a novel strategy for targeted protein ubiquitination
por: Jin, Jinmei, et al.
Publicado: (2020) -
Emerging protein degradation strategies: expanding the scope to extracellular and membrane proteins
por: Lin, Jiayi, et al.
Publicado: (2021) -
Oncolytic immunotherapy: multiple mechanisms of oncolytic peptides to confer anticancer immunity
por: Tang, Tianyu, et al.
Publicado: (2022) -
Peptide Stapling Applied to Antimicrobial Peptides
por: Lourenço, Ana Laura Pereira, et al.
Publicado: (2023) -
Bruceine D inhibits HIF-1α-mediated glucose metabolism in hepatocellular carcinoma by blocking ICAT/β-catenin interaction
por: Huang, Rui, et al.
Publicado: (2021)